Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Bibliographic Details
Main Authors:	Kriege, M, Hollestelle, A, Jager, A, Huijts, P E A, Berns, E M, Sieuwerts, A M, Meijer-van Gelder, M E, Collée, J M, Devilee, P, Hooning, M J, Martens, J W M, Seynaeve, C
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150261/

Similar Items

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
by: Kriege, Mieke, et al.
Published: (2015)

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
by: Massink, Maarten P. G., et al.
Published: (2015)

CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
by: Isinger, Anna, et al.
Published: (2006)

CHEK2 ∗1100delC Mutation and Risk of Prostate Cancer
by: Hale, Victoria, et al.
Published: (2014)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
by: Sanna Hallamies, et al.
Published: (2017-09-01)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
by: Muranen, Taru A, et al.
Published: (2011)

CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
by: Margolin, Sara, et al.
Published: (2007)

Frequency of CHEK2*1100delC in New York breast cancer cases and controls
by: Offit, Kenneth, et al.
Published: (2003)

Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer
by: Ding, Dapeng, et al.
Published: (2012)

The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population
by: Marouf, Chaymaa, et al.
Published: (2015)

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
by: Cierniková, S, et al.
Published: (2005)

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer
by: Francies, F. Z., et al.
Published: (2015)

Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk
by: Varley, Jenny, et al.
Published: (2003)

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
by: Liu, Jingjing, et al.
Published: (2016)

Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk
by: Einarsdóttir, Kristjana, et al.
Published: (2006)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
by: Drooger, Jan C., et al.
Published: (2015)

Patterns of metastasis in women with metachronous contralateral breast cancer
by: Vichapat, V, et al.
Published: (2012)

Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer
by: Lin, Wei-Yu, et al.
Published: (2013)

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
by: Wevers, M. R., et al.
Published: (2015)

Risk of contralateral breast cancer in Denmark 1943-80.
by: Storm, H. H., et al.
Published: (1986)

Frequency of CHEK2 mutations in a population based, case–control study of breast cancer in young women
by: Friedrichsen, Danielle M, et al.
Published: (2004)

The risk of breast cancer in women with a CHEK2 mutation
by: Cybulski, Cezary, et al.
Published: (2012)

CHEK2 mutations as markers for high risk of breast cancer
by: Cybulski, Cezary, et al.
Published: (2012)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
by: Jansen, M. P. H. M., et al.
Published: (2011)

Changes in mammographically normal contralateral breast in cases of breast carcinoma.
by: Prasad, A., et al.
Published: (1989)

CHEK2 contribution to hereditary breast cancer in non-BRCA families
by: Desrichard, Alexis, et al.
Published: (2011)

Case report: breast cancer associated with contralateral tuberculosis of axillary lymph nodes
by: Baslaim, Muna M, et al.
Published: (2013)

Determining the contralateral breast dose during radiotherapy of breast cancer using rainbow dosimeter
by: Sajad A. Rather, et al.
Published: (2014-10-01)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
by: Broeks, Annegien, et al.
Published: (2007)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
by: Davies, Kalatu R, et al.
Published: (2015)

Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.
by: Foekens, J. A., et al.
Published: (1993)

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
by: Langballe, Rikke, et al.
Published: (2016)

Quadra-Chek digital readouts
Published: (2002)

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy1
by: Chen, Jeon Hor, et al.
Published: (2015)

MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
by: Taneja, Sangeeta, et al.
Published: (2012)

The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty
by: Dogan, Lutfi, et al.
Published: (2011)

Only one breast remains at risk of contralateral cancer
by: Peto, R.
Published: (1987)

Myoepithelial carcinoma with contralateral invasive micropapillary carcinoma of the breast
by: Kwon, Sun Young, et al.
Published: (2011)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips, KA, et al.
Published: (2012)

The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population
by: Plonis J, et al.
Published: (2015-12-01)